ProShare Advisors
INFI

ProShare Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

ProShare Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,623
Closed -$29K – 2219
2022
Q1 		$29K Sell
25,623
-6,038
-19% -$7.21K ﹤0.01% 2156
2021
Q4 		$71K Buy
31,661
+20,445
+182% +$51.3K ﹤0.01% 2241
2021
Q3 		$38K Sell
11,216
-11,492
-51% -$35.4K ﹤0.01% 1980
2021
Q2 		$68K Buy
+22,708
New +$71.8K ﹤0.01% 2339
2016
Q4 		– Sell
-36,117
Closed -$56K – 1757
2016
Q3 		$56K Sell
36,117
-6,698
-16% -$10.3K ﹤0.01% 1438
2016
Q2 		$57K Buy
42,815
+294
+0.7% +$1.38K ﹤0.01% 1548
2016
Q1 		$224K Sell
42,521
-4,207
-9% -$25.7K ﹤0.01% 1359
2015
Q4 		$367K Buy
46,728
+4,534
+11% +$39K ﹤0.01% 1190
2015
Q3 		$357K Sell
42,194
-3,180
-7% -$29.3K 0.01% 1068
2015
Q2 		$497K Sell
45,374
-3,420
-7% -$43.9K 0.01% 1094
2015
Q1 		$682K Buy
48,794
+6,076
+14% +$92.9K 0.01% 1035
2014
Q4 		$722K Sell
42,718
-1,605
-4% -$23.4K 0.01% 1022
2014
Q3 		$595K Sell
44,323
-8,803
-17% -$105K 0.01% 1298
2014
Q2 		$677K Sell
53,126
-32,321
-38% -$337K 0.01% 1385
2014
Q1 		$1.02M Buy
85,447
+60,775
+246% +$816K 0.01% 1298
2013
Q4 		$341K Sell
24,672
-22,424
-48% -$317K 0.01% 1120
2013
Q3 		$822K Buy
47,096
+18,556
+65% +$355K 0.02% 1031
2013
Q2 		$464K Buy
+28,540
New +$883K 0.01% 1393

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ProShare Advisors's INFI Position: Q2 2022 in Review

ProShare Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 25,623 shares — an estimated $29K sold.

ProShare Advisors first reported a position in INFI in Q2 2013 and held it in 18 quarters. The position peaked at $1.02M in Q1 2014. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • ProShare Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 25,623 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $29K.
  • ProShare Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • ProShare Advisors's Infinity Pharmaceuticals, Inc. position peaked at $1.02M in Q1 2014.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.